FibroGen

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FibroGen and other ETFs, options, and stocks.

About FGEN

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer.

CEO

Enrique A. Conterno

CEOEnrique A. Conterno

Employees

566

Employees566

Headquarters

San Francisco, California

HeadquartersSan Francisco, California

Founded

1993

Founded1993

Employees

566

Employees566

FGEN Key Statistics

Market cap

1.22B

Market cap1.22B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

698.99K

Average volume698.99K

High today

$13.55

High today$13.55

Low today

$12.97

Low today$12.97

Open price

$13.20

Open price$13.20

Volume

734.22K

Volume734.22K

52 Week high

$16.91

52 Week high$16.91

52 Week low

$7.81

52 Week low$7.81

Analyst ratings

86%

of 7 ratings

Buy

Hold

85.7%

Sell

14.3%

FGEN Earnings

-$1.45

-$0.79

-$0.12

$0.54

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 8, After Hours

ActualExpected Nov 8, After Hours